ADVERTISEMENT
Effect of Proton Pump Inhibitor Use on Glioblastoma Survival Outcomes
Michael Castro, MD, Beverly Hills Cancer Center, California, discusses the results of a retrospective study evaluating the effect proton pump inhibition use may have on survival outcomes of patients with glioblastoma.
In this real-world evidence dataset, the use of proton pump inhibitors appeared to antagonize chemotherapy and have a negative impact on the survival of patients with glioblastoma.
Source:
Castro MP, Quinn J, Wasserman A, et al. Use of proton pump inhibitors (PPI) in glioblastoma (GBM) and relationship to overall survival in a national real-world evidence (RWE) database.
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement